Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-11
  • 2018-10
  • 2018-07
  • Ertapenem Sodium Salt: Applied Protocols for Resistance Rese

    2026-04-11

    Ertapenem Sodium Salt: Applied Protocols for Resistance Research

    Principle Overview: Targeting Bacterial Cell Wall Synthesis

    Ertapenem sodium salt is a 1-β-methyl carbapenem antibiotic with potent, broad-spectrum activity against diverse bacterial pathogens, including challenging Gram-positive and Gram-negative strains. Its primary mechanism of action centers on binding to penicillin-binding proteins (PBPs)—notably PBPs 2 and 3 in Escherichia coli—thereby inhibiting peptidoglycan cross-linking and rapidly compromising bacterial cell wall integrity [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html]. This high-affinity interaction underpins its efficacy in both routine and advanced antibiotic resistance profiling.

    Beyond its microbiological impact, the pharmacokinetics of ertapenem, including a plasma half-life of 3.8–4.4 hours and approximately 45% renal clearance, facilitate precise dosing and experimental timing [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html]. These properties make it an indispensable antibacterial agent for Gram-positive and Gram-negative bacteria in research contexts where reproducibility and quantitative rigor are vital.

    Step-by-Step Workflow: Optimizing Experimental Success

    Deploying Ertapenem (sodium salt) in laboratory workflows unlocks high-fidelity antibiotic resistance profiling and supports translational research into emerging multidrug-resistant phenotypes. The following protocol distills best practices for broth microdilution, resistance screening, and cell-based viability assays.

    Protocol Parameters

    • assay: Broth microdilution | value_with_unit: 0.125–32 mg/L | applicability: MIC determination for Gram-negative and Gram-positive strains | rationale: Captures the clinically relevant and experimentally validated MIC90 window for Enterobacteriaceae and Bacteroides fragilis group [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html]
    • assay: Stock solution preparation | value_with_unit: ≥52 mg/mL in sterile water | applicability: Ensures full solubility for accurate dosing | rationale: Ertapenem sodium salt is water-soluble ≥52 mg/mL, facilitating high-concentration stocks for precise dilution [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html]
    • assay: Incubation | value_with_unit: 16–20 h at 35±2°C | applicability: Standard conditions for bacterial growth inhibition assays | rationale: Aligns with CLSI guidelines and ensures reliable MIC readout [source_type: workflow_recommendation][source_link: https://carbenicillin-disodium-salt.com/index.php?g=Wap&m=Article&a=detail&id=16265]

    For resistance gene transmission studies, as demonstrated in the recent Guangdong CREC study, broth microdilution and PCR-based detection of carbapenemase-encoding genes (CEGs) offer a high-throughput, quantitative foundation for monitoring resistance dynamics [source_type: paper][source_link: https://doi.org/10.1186/s12866-025-04300-0].

    Key Innovation from the Reference Study

    The landmark study by Chen et al. (2025) systematically characterized the prevalence and mobility of carbapenemase-encoding genes—particularly blaNDM-1—within carbapenem-resistant Enterobacter cloacae isolates across eight major hospitals in Guangdong, China. Notably, the positive rate of CEGs reached 85.19%, with the blaNDM-1 gene present on both chromosomes and plasmids in a significant portion of isolates [source_type: paper][source_link: https://doi.org/10.1186/s12866-025-04300-0]. Plasmid conjugation experiments achieved a striking 95.65% transfer success for CEGs, underscoring the high risk of horizontal gene transfer in clinical settings.

    Translational impact: For researchers, these findings validate the use of Ertapenem sodium salt in workflows that couple phenotypic MIC assays with molecular genotyping (PCR, ERIC-PCR) to track resistance emergence and gene mobility. The high resolution of these combined approaches enables actionable surveillance and facilitates hypothesis-driven interventions against multidrug resistance.

    Advanced Applications & Comparative Advantages

    Ertapenem sodium salt stands apart in several research scenarios:

    • Resistance Profiling: Its well-characterized MIC90 values (<1 mg/L for most Enterobacteriaceae) enable benchmarking of multidrug-resistant isolates, including those harboring transferable CEGs [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html].
    • Pharmacokinetic Modeling: Investigators can leverage its predictable plasma half-life and high water solubility for pharmacodynamic simulation and dose-response studies, reducing experimental drift [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html].
    • Antibiotic Resistance Research: As illustrated in the Guangdong study, Ertapenem sodium salt is integral for mapping resistance gene transmission within and across clinical departments, supported by robust conjugation and PCR workflows [source_type: paper][source_link: https://doi.org/10.1186/s12866-025-04300-0].

    These strengths are echoed in prior resources: for example, "Broad-Spectrum Carbapenem Antibiotics" positions Ertapenem as a gold standard for resistance benchmarking, while "Mechanisms, Resistance, and Research Applications" extends this by providing mechanistic and translational insights. The current workflow complements these with actionable, protocol-driven guidance, directly addressing common pitfalls in experimental reproducibility.

    Troubleshooting & Optimization Tips

    • Solubility Challenges: If precipitation occurs at high concentrations, ensure water is used as the solvent and avoid DMSO unless ultrasonic assistance is available [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html]. Gentle warming (not exceeding 37°C) can aid dissolution but should not be prolonged to avoid degradation [source_type: workflow_recommendation][source_link: https://repirinastapis.com/index.php?g=Wap&m=Article&a=detail&id=119].
    • Maintaining Activity: Prepare working solutions fresh and store aliquots at -20°C; repeated freeze-thaw cycles can compromise potency [source_type: product_spec][source_link: https://www.apexbt.com/ertapenem-sodium-salt.html]. For stability, limit storage of diluted solutions to short-term experimental windows.
    • Assay Interference: To minimize variability in MIC or cell viability assays, calibrate inoculum density and verify media sterility. Reference the validated workflows outlined in "Applied Workflows for Antibiotic Resistance" for detailed procedural controls.
    • Genotypic/Phenotypic Discordance: When PCR-detected CEGs do not match phenotypic resistance (or vice versa), consider possible gene silencing, low-level expression, or mixed populations—integrating molecular and culture-based methods ensures comprehensive profiling [source_type: paper][source_link: https://doi.org/10.1186/s12866-025-04300-0].

    APExBIO’s stringent quality standards for Ertapenem sodium salt (SKU C3451) further support reproducibility and confidence in experimental outcomes.

    Future Outlook: Implications and Evolving Strategies

    The convergence of high-throughput genotyping, conjugation experiments, and quantitative MIC profiling—anchored by robust agents like Ertapenem sodium salt—marks a new era in antibiotic resistance research. The Guangdong study’s revelation of widespread, mobile CEGs, especially blaNDM-1, signals both an urgent clinical challenge and a research opportunity [source_type: paper][source_link: https://doi.org/10.1186/s12866-025-04300-0].

    Looking forward, integrated resistance surveillance platforms that combine molecular diagnostics with phenotypic assays will be vital for preempting outbreaks and refining therapeutic strategies. The continued adaptation of best-practice protocols—drawing on validated resources such as those from APExBIO—will further accelerate actionable insights in the fight against multidrug resistance.

    For researchers ready to advance their studies, Ertapenem (sodium salt) offers a rigorously characterized, bench-validated solution for high-impact scientific discovery.